Variant report
Variant | esv2476427 |
---|---|
Chromosome Location | chr9:12556260-12560271 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs372630817 | chr9:12556290-12556291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185698183 | chr9:12556291-12556292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373210453 | chr9:12556302-12556303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376611591 | chr9:12556327-12556328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs200344035 | chr9:12556336-12556337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190222099 | chr9:12556377-12556378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs180893889 | chr9:12556406-12556407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs147482226 | chr9:12556411-12556412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140022589 | chr9:12556412-12556413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554182792 | chr9:12556474-12556475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs183522163 | chr9:12556479-12556480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369087963 | chr9:12556507-12556508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539972929 | chr9:12556516-12556517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145219211 | chr9:12556559-12556560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576607067 | chr9:12556566-12556567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546215937 | chr9:12556573-12556574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542361718 | chr9:12556602-12556603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147621765 | chr9:12556605-12556606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572662545 | chr9:12556610-12556611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540645500 | chr9:12556624-12556625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563775144 | chr9:12556640-12556641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532758473 | chr9:12556652-12556653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543162405 | chr9:12556670-12556671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149103672 | chr9:12556746-12556747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562704322 | chr9:12556751-12556752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs28802375 | chr9:12556779-12556780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs142227771 | chr9:12556790-12556791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184104558 | chr9:12556798-12556799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201774080 | chr9:12559611-12559612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528955056 | chr9:12559632-12559633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542337390 | chr9:12559669-12559670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181144715 | chr9:12559698-12559699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528284550 | chr9:12559753-12559754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs551745251 | chr9:12559787-12559788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs186943759 | chr9:12559790-12559791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs111253274 | chr9:12559823-12559824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs533374905 | chr9:12559862-12559863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191829996 | chr9:12559872-12559873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570071054 | chr9:12559873-12559874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535971442 | chr9:12559917-12559918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs375396445 | chr9:12559926-12559927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555572364 | chr9:12559933-12559934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565981701 | chr9:12559985-12559986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs151131763 | chr9:12560002-12560003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558042129 | chr9:12560007-12560008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140091915 | chr9:12560010-12560011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543036297 | chr9:12560023-12560024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371285033 | chr9:12560102-12560103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs72700782 | chr9:12560115-12560116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs397736426 | chr9:12560119-12560120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:12555400-12556800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
2 | chr9:12559600-12560000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr9:12560000-12560400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |